×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ZTS – zoetis inc. class a (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ZTS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/5
09:10 am
zts
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats [Yahoo! Finance]
Low
Report
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats [Yahoo! Finance]
12/5
08:30 am
zts
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
Low
Report
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
12/4
10:58 am
zts
Zoetis Inc. (ZTS): A Bull Case Theory [Yahoo! Finance]
Low
Report
Zoetis Inc. (ZTS): A Bull Case Theory [Yahoo! Finance]
12/3
08:06 am
zts
Zoetis (NYSE:ZTS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $160.00 price target on the stock.
Low
Report
Zoetis (NYSE:ZTS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $160.00 price target on the stock.
12/2
11:46 am
zts
Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation Transcript [Seeking Alpha]
Low
Report
Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation Transcript [Seeking Alpha]
12/2
07:30 am
zts
Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
Low
Report
Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
11/26
04:15 pm
zts
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
Low
Report
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
11/20
05:05 pm
zts
Zoetis (NYSE:ZTS) is now covered by analysts at KeyCorp. They set a "sector weight" rating on the stock.
Medium
Report
Zoetis (NYSE:ZTS) is now covered by analysts at KeyCorp. They set a "sector weight" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/2
04:29 pm
zts
Form 3 Zoetis Inc. For: Dec 01 Filed by: Tilenius Stephanie
Low
Report
Form 3 Zoetis Inc. For: Dec 01 Filed by: Tilenius Stephanie
12/2
04:29 pm
zts
Form 4 Zoetis Inc. For: Dec 01 Filed by: Tilenius Stephanie
Low
Report
Form 4 Zoetis Inc. For: Dec 01 Filed by: Tilenius Stephanie
12/2
08:00 am
zts
Form 8-K Zoetis Inc. For: Dec 02
Low
Report
Form 8-K Zoetis Inc. For: Dec 02
11/4
03:03 pm
zts
Form 10-Q Zoetis Inc. For: Sep 30
Low
Report
Form 10-Q Zoetis Inc. For: Sep 30
11/4
07:06 am
zts
Form 8-K Zoetis Inc. For: Nov 04
Medium
Report
Form 8-K Zoetis Inc. For: Nov 04
10/28
08:34 am
zts
Form 8-K Zoetis Inc. For: Oct 23
Low
Report
Form 8-K Zoetis Inc. For: Oct 23
10/14
04:28 pm
zts
Form 4 Zoetis Inc. For: Oct 10 Filed by: FULLER JULIE
Low
Report
Form 4 Zoetis Inc. For: Oct 10 Filed by: FULLER JULIE
10/14
04:28 pm
zts
Form 4 Zoetis Inc. For: Oct 10 Filed by: Joseph Wetteny
Low
Report
Form 4 Zoetis Inc. For: Oct 10 Filed by: Joseph Wetteny
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/25
Form 4 Zoetis Inc. For: Mar 23 Filed by: STEERE WILLIAM C JR
9.0%
4/6 Form DEFA14A Zoetis Inc. 8.8%
8/6 Q2/2019 6/30/2019 EPS 0.900 ZacksConsensus 0.820 ActVsEst 0.080 - Beat 8.2%
12/18 Form 4 Zoetis Inc. For: Dec 16 Filed by: Lewis Clinton A. Jr. 6.4%
8/15 Zoetis to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference 5.7%
3/3 Form 4 Zoetis Inc. For: Mar 02 Filed by: Chen Heidi C. 4.6%
2/29 Zoetis Inc (NYSE: ZTS) had its "buy" rating re-affirmed by analysts at Goldman Sachs Group Inc. They now have a $162.00 price target on the stock. 4.3%
4/2 Zoetis Inc (NYSE: ZTS) had its price target lowered by analysts at Morgan Stanley from $148.00 to $125.00. They now have an "equal weight" rating on the stock. 3.4%
4/30 Innovative New Pet Health Start-up, Pumpkin Insurance Services, Launches in the U.S. 3.0%
10/3 Zoetis Declares Fourth Quarter 2019 Dividend 2.5%
4/6 Form DEFA14A Zoetis Inc. 8.8%
8/6 Q2/2019 6/30/2019 EPS 0.900 ZacksConsensus 0.820 ActVsEst 0.080 - Beat 8.2%
12/18 Form 4 Zoetis Inc. For: Dec 16 Filed by: Lewis Clinton A. Jr. 6.4%
8/15 Zoetis to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference 5.7%
3/3 Form 4 Zoetis Inc. For: Mar 02 Filed by: Chen Heidi C. 4.6%
2/29 Zoetis Inc (NYSE: ZTS) had its "buy" rating re-affirmed by analysts at Goldman Sachs Group Inc. They now have a $162.00 price target on the stock. 4.3%
4/2 Zoetis Inc (NYSE: ZTS) had its price target lowered by analysts at Morgan Stanley from $148.00 to $125.00. They now have an "equal weight" rating on the stock. 3.4%
4/30 Innovative New Pet Health Start-up, Pumpkin Insurance Services, Launches in the U.S. 3.0%
10/3 Zoetis Declares Fourth Quarter 2019 Dividend 2.5%
TOP News Decliners
3/6
Form 4 Zoetis Inc. For: Mar 05 Filed by: David Glenn
-4.4%
3/17 Form 3 Zoetis Inc. For: Mar 09 Filed by: Pudloski Sherry N -3.9%
2/21 Form 4 Zoetis Inc. For: Feb 19 Filed by: Alaix Juan Ramon -3.8%
10/22 Zoetis to Participate in the Credit Suisse 28th Annual Healthcare Conference -2.9%
9/9 Zoetis Scientists Present Positive Efficacy Data for Investigational Triple Combination Parasiticide at American Heartworm Society Meeting -2.9%
3/4 Markets Irrationally React To Coronavirus, Creating Buying Opportunity For Zoetis [Seeking Alpha] -2.8%
11/7 Form 8-K Zoetis Inc. For: Nov 07 -2.8%
4/2 Form 4 Zoetis Inc. For: Mar 31 Filed by: Lagano Roxanne -2.7%
2/24 Form 4 Zoetis Inc. For: Feb 21 Filed by: Alaix Juan Ramon -2.6%
4/17 Form 4 Zoetis Inc. For: Apr 15 Filed by: Lagano Roxanne -2.5%
3/17 Form 3 Zoetis Inc. For: Mar 09 Filed by: Pudloski Sherry N -3.9%
2/21 Form 4 Zoetis Inc. For: Feb 19 Filed by: Alaix Juan Ramon -3.8%
10/22 Zoetis to Participate in the Credit Suisse 28th Annual Healthcare Conference -2.9%
9/9 Zoetis Scientists Present Positive Efficacy Data for Investigational Triple Combination Parasiticide at American Heartworm Society Meeting -2.9%
3/4 Markets Irrationally React To Coronavirus, Creating Buying Opportunity For Zoetis [Seeking Alpha] -2.8%
11/7 Form 8-K Zoetis Inc. For: Nov 07 -2.8%
4/2 Form 4 Zoetis Inc. For: Mar 31 Filed by: Lagano Roxanne -2.7%
2/24 Form 4 Zoetis Inc. For: Feb 21 Filed by: Alaix Juan Ramon -2.6%
4/17 Form 4 Zoetis Inc. For: Apr 15 Filed by: Lagano Roxanne -2.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: